LENZ THERAPEUTICS, INC. (LENZ)
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
Pyxis Tankers Announces M/T “Pyxis Karteria” Safely Exits the Strait of Hormuz
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
Commvault Signs Multi-Year Strategic Partnership with Microsoft
Enbridge Selects Navan to Drive Reliable, User-Friendly Travel Booking Experience Through AI-Powered Travel and Expense Management
SEALSQ Calls for Accelerated Post-Quantum Cryptography Migration Across Europe at IQT Nordics 2026
Jet.AI Within 2.1% (29,594 Shares) of Securing Shareholder Approval for Proposed flyExclusive Transaction; Meeting Adjourned Until July 2
CVR Partners 2025 Schedule K-3 Now Available
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders